
Throughout May, June And July, All Donations Made To Parasites Without Borders Will Be Matched By PWB And Donated To Foundation For International Medical Relief Of Children
February 6, 2025
Co-infection of SARS‐CoV‐2 and Influenza A/B among Patients with COVID-19: A Systematic Review and Meta-analysis | Oseltamivir Reduces 30-Day Mortality in Older Adults with Influenza: A Pooled Analysis from the 2012-2019 Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)
January 30, 2025
Respiratory Syncytial Virus Vaccine Effectiveness among U.S. Veterans |
Transcutaneous Vagus Nerve Stimulation Improves Long COVID Symptoms in a Female Cohort |
Distinct Pro-inflammatory/Pro-angiogenetic Signatures Distinguish Children |
Persistent Symptoms and Clinical Findings in Adults with Post-acute Sequelae of COVID-19 Syndrome |
Impact of COVID-19 Pandemic on the Incidence and Prevalence of Postural Orthostatic Tachycardia Syndrome
January 23, 2025
Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial |
Host-microbe Multiomic Profiling Identifies Distinct COVID-19 Immune Dysregulation in Solid Organ Transplant Recipients |
Real‐world Effectiveness and Safety of Oral Azvudine versus Nirmatrelvir‒ritonavir (Paxlovid) in Hospitalized Patients with COVID-19: A Multicenter, Retrospective, Cohort Study
January 16, 2025
Antiviral Medications for Treatment of Nonsevere Influenza: A Systematic Review and Network Meta-Analysis |
Symptom Evolution in Individuals with Ongoing Symptomatic COVID-19 and Post COVID-19 Syndrome After SARS-CoV-2 Vaccination versus Influenza Vaccination |
Neurological Post-COVID Syndrome is Associated with Substantial Impairment of Verbal Short-term and Working Memory
January 9, 2025
Mpox Vaccination Hesitancy, Previous Immunization Coverage, and Vaccination Readiness in the African Region | Global Prevalence and Correlates of Mpox Vaccine Acceptance and Uptake |
The Effect of Nirmatrelvir/ritonavir on Short- and Long-term Adverse Outcomes from COVID-19 |
Epidemiological Insights into Chronic Urticaria, Vitiligo, Alopecia Areata, and Herpes Zoster following COVID-19 Infection | Impact of Extended-course Oral Nirmatrelvir/ritonavir in Established Long COVID
January 2, 2025
In-hospital Outcomes of Healthcare-associated Coronavirus Disease 2019 (Omicron) Versus Healthcare-associated Influenza: A Retrospective, Nationwide Cohort Study in Switzerland | Real Clinical Effectiveness of Molnupiravir Against 30-day Mortality Among 74, 41 SARS-CoV-2–Positive Patients: A Nationwide Cohort Study from the Czech Republic
- « Anterior
- 1
- 2
- 3
- 4
- 5
- …
- 44
- Siguiente »
Situation Dashboards

World Health Organization (WHO)
Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)

Johns Hopkins University (JHU)
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU

COVID-19 in US and Canada
1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources

Genomic Epidemiology COVID-19
Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.